A genome-wide meta-analysis identified multiple genetic loci associated with smoking behavior. The study, conducted by the Tobacco and Genetics Consortium (TAG) in collaboration with the European Network of Genetic and Genomic Epidemiology (ENGAGE) and Oxford-GlaxoSmithKline (Ox-GSK) consortia, analyzed data from over 74,000 individuals. The study identified three loci associated with the number of cigarettes smoked per day (CPD). The strongest association was a synonymous SNP (rs1051730[A]) in the nicotinic receptor gene CHRNA3, which was strongly linked to increased smoking quantity. Two SNPs in the 10q25 region and one in the EGLN2 gene also showed genome-wide significance for CPD. For smoking initiation, eight SNPs exceeded genome-wide significance, with the strongest association at a nonsynonymous SNP in the BDNF gene on chromosome 11. A SNP near the DBH gene on chromosome 9 was significantly associated with smoking cessation. The study also found that SNPs in regions on chromosomes 10q23 and 19q13 were significantly associated with CPD. The SNPs rs1329650[G] and rs1028936[A] were located in a noncoding RNA and were linked to increased smoking quantity. Additionally, a SNP in the EGLN2 gene on chromosome 19q13 was associated with CPD. The study also identified a SNP near the DBH gene on chromosome 9 that was associated with smoking cessation. The study highlights the genetic factors influencing smoking behavior, including the number of cigarettes smoked per day, smoking initiation, and smoking cessation. The findings suggest that separate genetic loci contribute modestly to phenotypic variability in each aspect of smoking behavior, which may have implications for the design and targeting of smoking cessation therapies and tobacco control efforts. The study's large sample size and comprehensive analysis provide valuable insights into the genetic basis of smoking behavior.A genome-wide meta-analysis identified multiple genetic loci associated with smoking behavior. The study, conducted by the Tobacco and Genetics Consortium (TAG) in collaboration with the European Network of Genetic and Genomic Epidemiology (ENGAGE) and Oxford-GlaxoSmithKline (Ox-GSK) consortia, analyzed data from over 74,000 individuals. The study identified three loci associated with the number of cigarettes smoked per day (CPD). The strongest association was a synonymous SNP (rs1051730[A]) in the nicotinic receptor gene CHRNA3, which was strongly linked to increased smoking quantity. Two SNPs in the 10q25 region and one in the EGLN2 gene also showed genome-wide significance for CPD. For smoking initiation, eight SNPs exceeded genome-wide significance, with the strongest association at a nonsynonymous SNP in the BDNF gene on chromosome 11. A SNP near the DBH gene on chromosome 9 was significantly associated with smoking cessation. The study also found that SNPs in regions on chromosomes 10q23 and 19q13 were significantly associated with CPD. The SNPs rs1329650[G] and rs1028936[A] were located in a noncoding RNA and were linked to increased smoking quantity. Additionally, a SNP in the EGLN2 gene on chromosome 19q13 was associated with CPD. The study also identified a SNP near the DBH gene on chromosome 9 that was associated with smoking cessation. The study highlights the genetic factors influencing smoking behavior, including the number of cigarettes smoked per day, smoking initiation, and smoking cessation. The findings suggest that separate genetic loci contribute modestly to phenotypic variability in each aspect of smoking behavior, which may have implications for the design and targeting of smoking cessation therapies and tobacco control efforts. The study's large sample size and comprehensive analysis provide valuable insights into the genetic basis of smoking behavior.